Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review.

Pariente G, Leibson T, Carls A, Adams-Webber T, Ito S, Koren G.

PLoS Med. 2016 Nov 1;13(11):e1002160. doi: 10.1371/journal.pmed.1002160. eCollection 2016 Nov. Review.

2.

Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.

Aweeka FT, Hu C, Huang L, Best BM, Stek A, Lizak P, Burchett SK, Read JS, Watts H, Mirochnick M, Capparelli EV; International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) P1026s Protocol Team.

HIV Med. 2015 Mar;16(3):176-83. doi: 10.1111/hiv.12195. Epub 2014 Nov 18.

3.

Clinical therapeutics in pregnancy.

Feghali MN, Mattison DR.

J Biomed Biotechnol. 2011;2011:783528. doi: 10.1155/2011/783528. Epub 2011 Jul 6.

4.

Selection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartum.

Ellis GM, Huang S, Hitti J, Frenkel LM; P1022 Study Team.

J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):241-7. doi: 10.1097/QAI.0b013e31822b4edc.

5.

German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

Buchholz B, Beichert M, Marcus U, Grubert T, Gingelmaier A, Haberl A, Schmied B; German AIDS Society; Austrian AIDS Society; HIV-AIDS Competence Network; Robert-Koch Institute Berlin; German Association of Physicians Specialized in HIV Care; German Society of Pediatric and Youth Medicine; German AIDS Pediatric Association; German Society of Obstetrics and Gynecology; National Reference Center for Retroviruses; German AIDS Assistance.

Eur J Med Res. 2009 Nov 3;14(11):461-79.

6.

Pregnancy does not increase CYP3A or P-glycoprotein activity in the non-human primate, Macaca nemestrina.

Zhang H, Wu X, Naraharisetti SB, Chung F, Whittington D, Mirfazaelian A, Unadkat JD.

J Pharmacol Exp Ther. 2009 Aug;330(2):586-95. doi: 10.1124/jpet.109.153569. Epub 2009 May 28.

7.

Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.

Yeh RF, Rezk NL, Kashuba AD, Dumond JB, Tappouni HL, Tien HC, Chen YC, Vourvahis M, Horton AL, Fiscus SA, Patterson KB.

Antimicrob Agents Chemother. 2009 Jun;53(6):2367-74. doi: 10.1128/AAC.01523-08. Epub 2009 Mar 23.

8.

Atazanavir: its role in HIV treatment.

Wood R.

Expert Rev Anti Infect Ther. 2008 Dec;6(6):785-96. doi: 10.1586/14787210.6.6.785. Review.

9.

Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Roustit M, Jlaiel M, Leclercq P, Stanke-Labesque F.

Br J Clin Pharmacol. 2008 Aug;66(2):179-95. doi: 10.1111/j.1365-2125.2008.03220.x. Epub 2008 May 15. Review.

10.

Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.

Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, Watts DH, Huang S, Hughes MD, Kaiser K, Purdue L, Asfaw Y, Keller M, Smith E; PACTG 353 Team.

HIV Clin Trials. 2008 Mar-Apr;9(2):115-25. doi: 10.1310/hct0902-115.

11.

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy.

Ghosn J, De Montgolfier I, Cornélie C, Dominguez S, Pérot C, Peytavin G, Marcelin AG, Pauchard M, Ouagari Z, Bonmarchand M, Agher R, Calvez V, Bricaire F, Dommergues M, Katlama C, Tubiana R.

Antimicrob Agents Chemother. 2008 Apr;52(4):1542-4. doi: 10.1128/AAC.01301-07. Epub 2008 Feb 4.

12.

A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.

von Hentig N, Carlebach A, Gute P, Knecht G, Klauke S, Rohrbacher M, Stocker H, Kurowski M, Harder S, Staszewski S, Haberl A.

Br J Clin Pharmacol. 2006 Nov;62(5):552-9.

13.

Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.

Villani P, Floridia M, Pirillo MF, Cusato M, Tamburrini E, Cavaliere AF, Guaraldi G, Vanzini C, Molinari A, degli Antoni A, Regazzi M.

Br J Clin Pharmacol. 2006 Sep;62(3):309-15.

15.

Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 women.

Hirt D, Treluyer JM, Jullien V, Firtion G, Chappuy H, Rey E, Pons G, Mandelbrot L, Urien S.

Antimicrob Agents Chemother. 2006 Jun;50(6):2079-86.

Supplemental Content

Support Center